本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Annovis Bio, Inc.

1.04
-0.0800-7.14%
盤後1.060.0201+1.93%19:51 EDT
成交量:143.28萬
成交額:156.38萬
市值:4,424.36萬
市盈率:-0.58
高:1.13
開:1.12
低:1.04
收:1.12
52周最高:5.50
52周最低:1.04
股本:4,254.19萬
流通股本:3,531.97萬
量比:1.02
換手率:4.06%
股息:- -
股息率:- -
每股收益(TTM):-1.7895
每股收益(LYR):-1.4040
淨資產收益率:-703.68%
總資產收益率:-142.36%
市淨率:-10.40
市盈率(LYR):-0.74

資料載入中...

2020/04/20

超過5%披露

General statement of acquisition of beneficial ownership
2020/04/03

重要事件披露

Current report, item 8.01
2020/03/25

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/02/06

重要事件披露

Current report, items 5.03 and 9.01
2020/01/30

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/24

SEC問詢函

[Cover]Correspondence
2020/01/24

SEC問詢函

[Cover]Correspondence
2020/01/24

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2020/01/21

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/12/10

[補充]招股説明書

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/19

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/09/20

SEC問詢函

[Cover]Correspondence
2019/09/20

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/08/28

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/08/27

SEC問詢函

[Cover]Correspondence
2019/08/08

SEC問詢函

[Cover]Correspondence
2019/08/08

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/07/03

招股説明書

General form for registration of securities under the Securities Act of 1933
2019/07/02

SEC問詢函

[Cover]Correspondence